Wealth Advisory Solutions’s AbbVie ABBV Stock Holding History

Wealth Advisory Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,190	Closed	-$211K	–	137
2024 Q4	$211K	Buy	+1,190	New	+$219K	0.06%	122
2022 Q3	–	Sell	-1,659	Closed	-$254K	–	132
2022 Q2	$254K	Buy	+1,659	New	+$254K	0.06%	130
2021 Q3	$731K	Buy	6,773 +4,395	+185%	+$502K	0.16%	94
2021 Q2	$268K	Sell	2,378 -5,056	-68%	-$569K	0.06%	141
2021 Q1	$805K	Buy	+7,434	New	+$795K	0.6%	35
2020 Q3	–	Sell	-2,297	Closed	-$226K	–	178
2020 Q2	$226K	Buy	+2,297	New	+$202K	0.06%	162

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wealth Advisory Solutions's ABBV Position: Q1 2025 in Review

Wealth Advisory Solutions sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,190 shares — an estimated $211K sold.

Wealth Advisory Solutions first reported a position in ABBV in Q2 2020 and held it in 6 quarters. The position peaked at $805K in Q1 2021. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Wealth Advisory Solutions reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Wealth Advisory Solutions sold 1,190 AbbVie shares in Q1 2025, an estimated $211K.
Wealth Advisory Solutions first reported a position in AbbVie in Q2 2020 and held it in 6 quarters.
Wealth Advisory Solutions's AbbVie position peaked at $805K in Q1 2021.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Wealth Advisory Solutions's 13F filing for Q1 2025, filed 30 Apr 2025.